Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Original Articles

Rasagiline Mesylate, a New Mao-B Inhibitor for the Treatment of Parkinson's Disease: A Double-Blind Study as Adjunctive Therapy to Levodopa

Rabey, J. M.; Sagi, I.; Huberman, M.; Melamed, E.; Korczyn, A.; Giladi, N.; Inzelberg, R.; Djaldetti, R.; Klein, C.; Berecz, G.Rasagiline Study Group

Author Information
  • Buy

Abstract

© 2000 Lippincott Williams & Wilkins, Inc.